BCL2L11 Is Associated With Kawasaki Disease in Intravenous Immunoglobulin Responder Patients

Young-Chang Kwon; Jae-Jung Kim; Sin Weon Yun; Jeong Jin Yu; Kyung Lim Yoon; Kyung-Yil Lee; Hong-Ryang Kil; Gi Beom Kim; Myung-Ki Han; Min Seob Song; Hyoung Doo Lee; Kee Soo Ha; Sejung Sohn; Young Mi Hong; Gi Young Jang; Jong-Keuk Lee; Korean Kawasaki Disease Genetics Consortium

doi:10.1161/CIRCGEN.117.002020

BCL2L11 Is Associated With Kawasaki Disease in Intravenous Immunoglobulin Responder Patients

Circ Genom Precis Med. 2018 Feb;11(2):e002020. doi: 10.1161/CIRCGEN.117.002020.

Authors

Young-Chang Kwon¹, Jae-Jung Kim¹, Sin Weon Yun¹, Jeong Jin Yu¹, Kyung Lim Yoon¹, Kyung-Yil Lee¹, Hong-Ryang Kil¹, Gi Beom Kim¹, Myung-Ki Han¹, Min Seob Song¹, Hyoung Doo Lee¹, Kee Soo Ha¹, Sejung Sohn¹, Young Mi Hong¹, Gi Young Jang¹, Jong-Keuk Lee²; Korean Kawasaki Disease Genetics Consortium

Affiliations

¹ From the Asan Institute for Life Sciences (Y.-C.K., J.-J.K., J.-K.L) and Department of Pediatrics, Asan Medical Center (J.J.Y.), University of Ulsan College of Medicine, Seoul, Korea; Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea (S.W.Y.); Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Seoul, Korea (K.L.Y.); Department of Pediatrics, The Catholic University of Korea, Daejeon St. Mary's Hospital, Daejeon, Korea (K.-Y.L.); Department of Pediatrics, Chungnam National University Hospital, Daejeon, Korea (H.-R.K.); Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea (G.B.K.); Department of Pediatrics, University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea (M.-K.H.); Department of Pediatrics, Inje University Paik Hospital, Busan, Korea (M.S.S.); Department of Pediatrics, Pusan National University Hospital, Busan, Korea (H.D.L.); Department of Pediatrics, Korea University Hospital, Seoul, Korea (K.S.H., G.Y.J.); and Department of Pediatrics, Ewha Womans University Hospital, Seoul, Korea (S.S., Y.M.H.).
² From the Asan Institute for Life Sciences (Y.-C.K., J.-J.K., J.-K.L) and Department of Pediatrics, Asan Medical Center (J.J.Y.), University of Ulsan College of Medicine, Seoul, Korea; Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea (S.W.Y.); Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Seoul, Korea (K.L.Y.); Department of Pediatrics, The Catholic University of Korea, Daejeon St. Mary's Hospital, Daejeon, Korea (K.-Y.L.); Department of Pediatrics, Chungnam National University Hospital, Daejeon, Korea (H.-R.K.); Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea (G.B.K.); Department of Pediatrics, University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea (M.-K.H.); Department of Pediatrics, Inje University Paik Hospital, Busan, Korea (M.S.S.); Department of Pediatrics, Pusan National University Hospital, Busan, Korea (H.D.L.); Department of Pediatrics, Korea University Hospital, Seoul, Korea (K.S.H., G.Y.J.); and Department of Pediatrics, Ewha Womans University Hospital, Seoul, Korea (S.S., Y.M.H.) [email protected].

PMID: 29453247
DOI: 10.1161/CIRCGEN.117.002020

No abstract available

Keywords: genome wide association study; immunoglobulins, intravenous; mucocutaneous lymph node syndrome; polymorphism, single nucleotide.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bcl-2-Like Protein 11* / genetics
Humans
Immunoglobulins, Intravenous* / therapeutic use
Mucocutaneous Lymph Node Syndrome* / drug therapy
Mucocutaneous Lymph Node Syndrome* / genetics

Substances

BCL2L11 protein, human
Bcl-2-Like Protein 11
Immunoglobulins, Intravenous